MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 44 filers reported holding MERUS N V in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,000,000 | -51.4% | 250,000 | -34.9% | 0.07% | -57.8% |
| Q2 2020 | $6,179,000 | +2.1% | 384,000 | -23.2% | 0.17% | -32.4% |
| Q1 2020 | $6,050,000 | -14.1% | 500,000 | 0.0% | 0.26% | -5.9% |
| Q4 2019 | $7,040,000 | -21.0% | 500,000 | 0.0% | 0.27% | -23.8% |
| Q3 2019 | $8,910,000 | +73.8% | 500,000 | +42.9% | 0.36% | +72.5% |
| Q2 2019 | $5,128,000 | +15.7% | 350,000 | +16.7% | 0.21% | +14.4% |
| Q1 2019 | $4,431,000 | +53.5% | 300,000 | +45.5% | 0.18% | +69.2% |
| Q4 2018 | $2,886,000 | – | 206,125 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,712,000 | 6.04% |
| BVF INC/IL | 7,285,071 | $153,496,000 | 5.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 320,815 | $6,760,000 | 3.02% |
| Burrage Capital Management LLC | 130,683 | $2,753,000 | 2.76% |
| MPM BioImpact LLC | 700,879 | $14,768,000 | 2.43% |
| Boxer Capital, LLC | 1,900,000 | $40,033,000 | 1.41% |
| Octagon Capital Advisors LP | 206,927 | $4,360,000 | 0.90% |
| DAFNA Capital Management LLC | 157,841 | $3,326,000 | 0.70% |
| Ghost Tree Capital, LLC | 75,000 | $1,580,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 286,506 | $6,037,000 | 0.41% |